<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01428375</url>
  </required_header>
  <id_info>
    <org_study_id>PARACETAMOL-INTRAPARTUM</org_study_id>
    <secondary_id>PARACETAMOL-INTRAPARTUM</secondary_id>
    <nct_id>NCT01428375</nct_id>
  </id_info>
  <brief_title>Intravenous Infusion of Paracetamol for Intrapartum Analgesia of Labor</brief_title>
  <official_title>Evaluation of Intravenous Infusion of Paracetamol as Intrapartum Analgesic in the First Stage of Labor: a Double-blind Randomized Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Ain Shams University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Ain Shams University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is a double-blind randomized trial evaluates the efficacy of intravenous infusion of
      Paracetamol as intrapartum analgesic in the first stage of labour.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Comparison of efficacy and safety of intravenous infusion of paracetamol versus placebo
      (intravenous sterile water infusion) in parturient women in active first phase of labour and
      requiring intrapartum analgesia.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>August 2011</start_date>
  <completion_date type="Actual">October 2012</completion_date>
  <primary_completion_date type="Actual">October 2012</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Triple (Participant, Care Provider, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>To assess the efficacy of intravenous infusion of paracetamol in comparison with placebo (sterile water for injection) in labouring women</measure>
    <time_frame>Start of medication till end of first stage of labour. Participants will be followed for the duration of labour, an expected average of 8 hours.</time_frame>
    <description>By recoding the need for a rescue additional analgesia and measuring the degree of pain relief (Visual analogue score) during the labor process.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>To document safety</measure>
    <time_frame>Start of medication till delivery and neonatal assesment. Participants will be followed during this duration of labour, an expected average of 10 hours.</time_frame>
    <description>By assessing the adverse events recorded during the study either maternal or fetal/neonatal.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>To correlate with the duration of labor</measure>
    <time_frame>Start of medication till end of second stage of labour. Participants will be followed for the duration of labour, an expected average of 9 hours.</time_frame>
    <description>The difference between both groups regarding labour duration</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">120</enrollment>
  <condition>Labor Pain</condition>
  <arm_group>
    <arm_group_label>(1) Active (Paracetamol) arm: n=60</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>(Paracetamol)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>(2) Placbo (Sterile water) arm: n=60</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Sterile water</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>(1) Paracetamol injection</intervention_name>
    <description>Drugs: (1) Bottle containing 1000 mg Paracetamol in 100 ml solution for intravenous infusion</description>
    <arm_group_label>(1) Active (Paracetamol) arm: n=60</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Sterile water</intervention_name>
    <description>Drugs: (2) Bottle containing 100 ml sterile water for intravenous infusion</description>
    <arm_group_label>(2) Placbo (Sterile water) arm: n=60</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Age between 18-35 years.

          2. Primigravida.

          3. The gestational age between 37- 42 weeks.

          4. Patient seeking analgesia.

          5. Single viable fetus.

          6. Vertex presentation.

          7. Spontaneous onset of labor.

          8. 1st stage of labor with cervical dilatation 3-4 cm ( in active phase).

        Exclusion Criteria:

          1. Extreme of age (below 18-above 35).

          2. Multiparity.

          3. Multiple gestation.

          4. Malpresentation.

          5. Major degree of cephalopelvic disproportion.

          6. Any medical disorder with pregnancy e.g., Rheumatic heart disease, Diabetes mellitus,
             Hypertension, Anemia.

          7. Induction of labor.

          8. Cervical dilatation exceeds exceeding 4 cm.

          9. Use of any other kind of analgesia before recruitment in the study.

         10. Scared uterus.

         11. Fetal distress.

         12. Antepartum hemorrhage.

         13. Intrapartum bleeding.

         14. Polyhydramnios.

         15. Pre-mature rupture of membranes.

         16. Intra uterine infections.

         17. Hypersensitivity to paracetamol.
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>35 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Ahmed E Elbohoty, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>OB GYN Department, faculty of Medicine, ASU</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Ain Shams Maternity Hospital</name>
      <address>
        <city>Cairo</city>
        <country>Egypt</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Egypt</country>
  </location_countries>
  <verification_date>February 2013</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>August 15, 2011</study_first_submitted>
  <study_first_submitted_qc>September 1, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 5, 2011</study_first_posted>
  <last_update_submitted>February 4, 2013</last_update_submitted>
  <last_update_submitted_qc>February 4, 2013</last_update_submitted_qc>
  <last_update_posted type="Estimate">February 6, 2013</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Ain Shams University</investigator_affiliation>
    <investigator_full_name>Ahmed Elsayed Hassan Elbohoty</investigator_full_name>
    <investigator_title>Lecturer in OB GYN</investigator_title>
  </responsible_party>
  <keyword>intravenous paracetamol</keyword>
  <keyword>intrapartum analgesia</keyword>
  <keyword>labor pain</keyword>
  <keyword>intrapartum pains</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Labor Pain</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Acetaminophen</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

